OncoCyte Corporation (OCX) Tops Q2 EPS by 27c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts OCX Hot Sheet
Join SI Premium – FREE
OncoCyte Corporation (NASDAQ: OCX) reported Q2 EPS of ($1.03), $0.27 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $460 thousand versus the consensus estimate of $362.5 thousand.
For earnings history and earnings-related data on OncoCyte Corporation (OCX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Top oil & gas exploration stocks, according to Mizuho
- University Bancorp acquires remaining 20% of UIF for $15.2M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
